Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Articles by From the College

Joint Letter to CMS Advocates Against Adding Stelara to Self-Administered Drug List

From the College  |  July 6, 2020

The ACR, CSRO and Arthritis Foundation asked the Centers for Medicare & Medicaid Services to review the decision to add Stelara to the Self-Administered Drugs list, which would limit access for patients who can’t self-administer.

ACR Releases COVID-19 Clinical Guidance for Pediatric Patients

From the College  |  June 18, 2020

The ACR has developed two new clinical guidance documents for pediatric patients in the context of the COVID-19 pandemic.

The ACR on Air Podcast’s COVID-19 Series

From the College  |  June 15, 2020

In light of the current COVID-19 pandemic, the ACR has dedicated a few episodes of the ACR on Air podcast to the challenges that have arisen, along with information about the available resources and guidance. The first episode in this special series looks at drug shortages surrounding hydroxy­chloroquine (HCQ) and its initial uses to treat…

The COVID-19 Pandemic & the ACR’s Response

From the College  |  June 15, 2020

The ACR has been working on many levels to assist the rheumatology community during the COVID-19 pandemic, and we are focusing our efforts on areas critical for rheumatologists and rheumatology professionals, practices and patients. Because the pandemic poses many clinical and economic challenges, the ACR will continue to monitor this fast-paced, ever-changing situation and provide…

Foundation’s Award Provides Research Opportunity for Community-Based Practitioners

From the College  |  June 15, 2020

Rheumatologists in community-based practices work closely with patients, which allows them to notice trends and nuances researchers may not. Unfortunately, few opportunities exist for rheumatologists to test their observations through research, in addition to taking care of patients. Limited funding, time constraints and competition from larger academic medical centers are some of the barriers that…

Collaborate, Innovate & Learn at ACR Convergence 2020: The ACR’s All-Virtual Annual Meeting

From the College  |  June 11, 2020

ACR Convergence 2020—the ACR’s annual meeting—will be presented online. Get ready for an innovative experience.

An Important Message from the ACR on the Death of George Floyd

From the College  |  June 11, 2020

The American College of Rheumatology is deeply troubled by the recent events surrounding the death of George Floyd. This tragedy is the latest in a long history of senseless killings of people of color. We recognize that racial inequality is an invisible undercurrent impacting the lives of many of our members and patients, and we…

ACR Continues to Advocate Against Payer Mandates on Specialty Pharmacy Acquisition of In-Office Treatments

From the College  |  June 5, 2020

Despite efforts by the ACR and other organizations, Blue Cross Blue Shield of Tennessee has indicated that it will move forward with implementation of its specialty pharmacy acquisition mandate on July 1, 2020.

RheumPAC Hosts Rep. Ami Bera (D-Calif.) for Virtual Discussion of ACR Legislative Priorities

From the College  |  May 20, 2020

Top RheumPAC donors attended a virtual legislative update and Q&A with Rep. Ami Bera (D-Calif.) shortly after the release of House Democrats’ $3 trillion coronavirus response plan.

UnitedHealthCare Rescinds Planned Changes to Orencia Policy

From the College  |  May 6, 2020

UnitedHealthcare (UHC) is rescinding changes to its Orencia policy previously scheduled to go into effect July 1, 2020. These changes would have required patients to fail to respond to the self-administered formulation of the drug prior to obtaining authorization for the physician-administered product. Some patients on Orencia received notices from UHC in late April stating…

  • « Previous Page
  • 1
  • …
  • 25
  • 26
  • 27
  • 28
  • 29
  • …
  • 95
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences